Skip to main content
Tuoxin Pharmaceutical Group Co.,Ltd. logo

Tuoxin Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 301089 ISIN · CNE100004YC3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 734 across all filing types
Latest filing 2025-05-30 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 301089

About Tuoxin Pharmaceutical Group Co.,Ltd.

https://www.tuoxinpharm.com

Tuoxin Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and distribution of nucleosides and nucleotides. The company serves as a major global supplier of active pharmaceutical ingredients (APIs) and chemical intermediates. Its core product portfolio includes cytidine, inosine, guanosine, adenosine, and their various derivatives, which are essential components in the synthesis of antiviral, anti-tumor, and cardiovascular medications. Notably, the group provides key intermediates for drugs such as Ribavirin and Azvudine. Tuoxin Pharmaceutical leverages advanced synthetic biotechnology and large-scale manufacturing capabilities to support the global pharmaceutical industry. The company maintains a focus on technological innovation and quality control to ensure the stability and purity of its chemical products for diverse therapeutic applications.

Recent filings

Filing Released Lang Actions
关于公司控股股东、实际控制人之一致行动人减持公司股份触及1%整数倍的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the reduction of shareholding by a controlling shareholder and their concerted parties, detailing the number of shares reduced, the percentage of total share capital affected, and compliance with relevant securities laws. It includes specifics about the shareholder, shareholding percentages before and after the transaction, and the method of share reduction. This type of document is a notification of a major shareholding change, specifically when the shareholding crosses a 1% threshold. It is not a financial report, earnings release, or management discussion, nor is it a proxy or voting result announcement. The content fits the definition of a Major Shareholding Notification (MRQ). The document length is short and focused on shareholding changes, confirming MRQ classification with high confidence.
2025-05-30 Chinese
股票交易异常波动的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding abnormal stock trading fluctuations of the company 拓新药业集团股份有限公司. It details the stock price deviation over specific dates, investigation results about insider trading and undisclosed information, and risk warnings to investors. It does not contain financial statements or detailed financial performance data but rather focuses on regulatory disclosure about stock price movements and compliance with disclosure rules. The document length is short (1611 characters) and it is an announcement about stock trading irregularities, not a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-05-16 Chinese
2024年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement from the 2024 Annual General Meeting (AGM) of shareholders of the company 拓新药业集团股份有限公司. It details the meeting date, attendance, voting results on various proposals including approval of the 2024 annual report, board and supervisory reports, financial statements, profit distribution plan, remuneration plan, internal control report, and other related matters. The document is primarily focused on the voting results and resolutions passed at the AGM rather than the full annual report or financial statements themselves. The length is about 4521 characters, which is relatively short and consistent with an announcement of voting results rather than the full report. Therefore, this document fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-05-16 Chinese
北京市康达律师事务所关于拓新药业集团股份有限公司2024年年度股东大会的法律意见书.
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2024 Annual General Meeting (AGM) of a company. It details the procedures for convening and holding the AGM, the qualifications of attendees, the voting procedures, and the voting results on various agenda items including the 2024 annual report, board and supervisory reports, financial statements, profit distribution, remuneration plans, internal control reports, use of raised funds, and appointment of auditors. The document is not the annual report itself but a legal opinion on the AGM process and voting results. This fits the definition of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting outcomes of the AGM. The document length is sufficient and contains detailed voting results, not just an announcement of a report publication or a brief notice. Therefore, the correct classification is DVA with high confidence.
2025-05-16 Chinese
关于公司控股股东、实际控制人之一致行动人减持公司股份触及1%整数倍的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the reduction of shareholding by a controlling shareholder and their concerted actor, detailing the number of shares reduced, the percentage of total share capital affected, and compliance with relevant securities laws. It includes specifics about the shareholder, shareholding before and after the reduction, and the method of reduction. This type of document is a notification of a major shareholding change, specifically a reduction crossing a 1% threshold. It is not a full financial report, earnings release, or management report, nor is it a regulatory certification or proxy material. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length is short and focused on shareholding changes, confirming this classification with high confidence.
2025-05-16 Chinese
关于子公司变更食品生产许可证的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about its subsidiary obtaining a change in a food production license, including details about the license and the strategic value of the change. It does not contain financial statements, earnings data, or detailed financial analysis. It is a regulatory announcement about a business operational update related to licensing. The document length is short (924 characters), and it is an announcement rather than a report. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-05-15 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.